AG真人官方

Renwick John, Acting Chief Financial Officer of Kellanova (K), reported insider transactions dated 08/18/2025. 6,504 restricted stock units vested and converted into 6,504 shares at a $0 per-share issuance value. On the same date, he disposed of 2,869 shares at $80.02 per share. After these transactions, his direct beneficial ownership is reported as 61,970.6849 shares and he also holds 3,808.213 shares indirectly through a 401(k) profit sharing plan. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing discloses share vesting, a contemporaneous sale, and the resulting direct and indirect holdings.

Todd W. Haigh, Chief Legal Officer of Kellanova (K), reported multiple transactions on 08/15/2025. He received 5,803 restricted stock units that convert one-for-one into Kellanova common shares and were recorded at $0 per unit as compensation. On the same date he also disposed of 2,351 common shares at a price of $80.19, reducing his direct holdings from 33,990.1254 shares to 31,639.1254 shares. The filing notes an additional 100 shares held in a 401(k)/profit sharing plan and 349.64 shares in his parent's IRA for which he disclaims beneficial ownership.

Gund G. Zachary, a director of Kellanova (K), filed a Form 4 reporting transactions dated 08/15/2025. The filing shows an acquisition of 327.82 phantom stock units under the Kellanova Deferred Compensation Plan for Non-Employee Directors, with a reported unit price of $79.92. After the transaction, the filing reports 22,775.686 shares beneficially owned directly. The report also discloses multiple indirect holdings held in trusts and family partnerships (31,967.854; 9,200; 34,296; and 1,409,000 shares), each accompanied by disclaimers that the reporting person disclaims beneficial ownership except to the extent of pecuniary interest. The phantom units are payable in stock at the reporting person鈥檚 retirement per plan terms.

Stephanie Burns, a Kellanova director, reported transactions on 08/15/2025. The filing shows 34,537.594 shares of Kellanova common stock held indirectly in trust, excluding dividends reinvested after January 1, 2025. Under the company鈥檚 Deferred Compensation Plan for Non-Employee Directors, she acquired 163.91 phantom stock units on 08/15/2025, each with a reporting price of $79.92, which convert to common stock on retirement and are payable in shares. Following the reported derivative acquisition, Ms. Burns directly owns 12,751.487 common shares. The form was signed by an attorney-in-fact.

Kellanova (K) insider filing shows the W.K. Kellogg Foundation Trust sold 114,583 shares of K common stock on 08/14/2025 at a reported price of $80.0734 per share, leaving the Trust with 45,326,620 shares after the transaction. The filing identifies the Trust as a reporting person with the Foundation as sole beneficiary and lists trustees and Northern Trust Company acting as corporate trustee. The sale was made pursuant to trading instructions dated May 7, 2024 that are intended to comply with Rule 10b5-1(c).

Northern Trust Corporation reports beneficial ownership of 49,661,119 shares of Kellanova common stock, representing 14.3% of the class. The holding is reported as a mix of 3,331,001 shares with sole voting power and 46,327,324 shares with shared voting power; sole dispositive power is 3,267,978 and shared dispositive power is 46,358,785. The filing is a Schedule 13G, and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

The Northern Trust Company is identified as the relevant subsidiary related to these holdings. The statement discloses material ownership levels and the allocation of voting and dispositive powers without indicating any intent to alter corporate control.

The W.K. Kellogg Foundation Trust reported a sale of 114,583 shares of Kellanova common stock on 08/07/2025 at an aggregate price of $79.97 per share. After the reported transaction, the Trust and related Foundation beneficially owned 45,441,203 shares.

The filing identifies the Trust as the reporting person with trustees named and the W.K. Kellogg Foundation as sole beneficiary. The sale was executed pursuant to trading instructions given on May 7, 2024 that are intended to comply with Rule 10b5-1(c), and the Form 4 discloses the transaction and resulting holdings.

Kellanova (K) Form 144 discloses that long-time shareholder W.K. Kellogg Foundation Trust plans to sell an additional 458,332 common shares through BofA Securities on or after 08-07-2025. At the recent market price used in the filing, the block is valued at $36.65 million.

The Trust has already sold 12 identical blocks of 114,583 shares between 05-07-2025 and 07-28-2025, totaling roughly 1.375 million shares and 鈮�$111 million in gross proceeds. Including the new notice, sales over the rolling three-month window would reach 鈮�1.83 million shares, or 鈮�0.53 % of Kellanova鈥檚 345.2 million shares outstanding. The Trust acquired the stock via gifts and bequests dating back to 1970.

No officers or directors are named; therefore the filing reflects non-insider, charitable trust selling. While the percentage is modest, continued weekly liquidity events could create a short-term supply overhang and may be interpreted as incremental selling pressure.